Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rangering i aksjer #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Aksjekurs
$2.03
Markedsverdi
$121.44M
Endring (1 dag)
-0.93%
Endring (1 år)
-1.97%
Land
FR
Handel Crossject Société Anonyme (ALCJ)

Kategori

EPS for Crossject Société Anonyme (ALCJ)
EPS per December 2025 TTM: $-0.25
Ifølge de siste økonomiske rapportene og aksjekursen til Crossject Société Anonyme er selskapets nåværende EPS (TTM) $-0.25. Ved slutten av 2023 hadde selskapet en EPS på $-0.25, en nedgang sammenlignet med EPS-en i 2022 som var $-0.33.
EPS-historikk for Crossject Société Anonyme fra 2010 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.25 -15.03%
2024 $-0.29 14.59%
2023 $-0.25 -23.52%
2022 $-0.33 -30.38%
2021 $-0.48 -4.35%
2020 $-0.50 23.62%
2019 $-0.40 -55.51%
2018 $-0.91 -8.85%
2017 $-1.00 7.56%
2016 $-0.93 5.28%
2015 $-0.88 11.82%
2014 $-0.79 68.20%
2013 $-0.47 68.81%
2012 $-0.28 -161.13%
2011 $0.45 -136.44%
2010 $-1.24 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$8.37 -3,496.92%
US
$5.91 -2,499.88%
FR
$0.56 -326.26%
DE
$4.93 -2,102.39%
JP
$3.95 -1,703.08%
US